UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A review of osteocyte function and the emerging importance of sclerostin

Journal of bone and joint surgery. American volume, 2014-10, Vol.96 (19), p.1659-1668

2014

Volltextzugriff (PDF)

Gremlin 1 Identifies a Skeletal Stem Cell with Bone, Cartilage, and Reticular Stromal Potential

Cell, 2015-01, Vol.160 (1-2), p.269-284

2015

Volltextzugriff (PDF)

Bone Quality and Fracture-Healing in Type-1 and Type-2 Diabetes Mellitus

Journal of bone and joint surgery. American volume, 2019-08, Vol.101 (15), p.1399-1410

2019

Volltextzugriff (PDF)

Efficient differentiation of human iPSC-derived mesenchymal stem cells to chondroprogenitor cells

Journal of cellular biochemistry, 2013-02, Vol.114 (2), p.480-490

2013

Volltextzugriff (PDF)

The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants

Cancer research (Chicago, Ill.), 2006-06, Vol.66 (11), p.5790-5797

2006

Volltextzugriff (PDF)

Preclinical discovery of ixabepilone, a highly active antineoplastic agent

Cancer chemotherapy and pharmacology, 2008-12, Vol.63 (1), p.157-166

2008

Volltextzugriff (PDF)

Targeting Multiple Kinase Pathways in Leukemic Progenitors and Stem Cells Is Essential for Improved Treatment of Ph⁺ Leukemia in Mice

Proceedings of the National Academy of Sciences - PNAS, 2006-11, Vol.103 (45), p.16870-16875

2006

Volltextzugriff (PDF)

Transcriptomic identification of genes expressed in invasive S. aureus diabetic foot ulcer infection

Frontiers in cellular and infection microbiology, 2023-06, Vol.13, p.1198115

2023

Volltextzugriff (PDF)

Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)–based mutagenesis screen: high efficacy of drug combinations

Blood, 2006-10, Vol.108 (7), p.2332-2338

2006

Volltextzugriff (PDF)

Action of the src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (20), p.9185-9189

2005

Volltextzugriff (PDF)

In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants

Cancer research (Chicago, Ill.), 2005-06, Vol.65 (11), p.4500-4505

2005

Volltextzugriff (PDF)

Additive manufacturing of hydrogel-based materials for next-generation implantable medical devices

Science robotics, 2017-01, Vol.2 (2)

2017

Volltextzugriff (PDF)

Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival

Cancer research (Chicago, Ill.), 2006-06, Vol.66 (11), p.5542-5548

2006

Volltextzugriff (PDF)

Metabolism and disposition of dasatinib after oral administration to humans

Drug metabolism and disposition, 2008-07, Vol.36 (7), p.1357-1364

2008

Volltextzugriff (PDF)

Stem cell‐directed therapies for osteoarthritis: The promise and the practice

Stem cells (Dayton, Ohio), 2020-04, Vol.38 (4), p.477-486

2020

Volltextzugriff (PDF)

Comparative Analysis of Two Clinically Active BCR-ABL Kinase Inhibitors Reveals the Role of Conformation-Specific Binding in Resistance

Proceedings of the National Academy of Sciences - PNAS, 2005-03, Vol.102 (9), p.3395-3400

2005

Volltextzugriff (PDF)

Unique Spatial Transcriptomic Profiling of the Murine Femoral Fracture Callus: A Preliminary Report

Cells (Basel, Switzerland), 2024-03, Vol.13 (6), p.522

2024

Volltextzugriff (PDF)

Concurrent targeting of glycolysis in bacteria and host cell inflammation in septic arthritis

EMBO molecular medicine, 2022-12, Vol.14 (12), p.e15284-n/a

2022

Volltextzugriff (PDF)

Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL

Cancer chemotherapy and pharmacology, 2008-03, Vol.61 (3), p.365-376

2008

Volltextzugriff (PDF)

Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on src kinase for survival

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (6), p.2800-2808

2007

Volltextzugriff (PDF)

Re-appraising the potential of naringin for natural, novel orthopedic biotherapies

Therapeutic Advances in Musculoskeletal Disease, 2020, Vol.12, p.1759720X20966135-1759720X20966135

2020

Volltextzugriff (PDF)

Preclinical efficacy spectrum and pharmacokinetics of ixabepilone

Cancer chemotherapy and pharmacology, 2009, Vol.63 (2), p.201-212

2009

Volltextzugriff (PDF)

Parathyroid hormone therapy improves MRSA-infected fracture healing in a murine diabetic model

Frontiers in cellular and infection microbiology, 2023-09, Vol.13, p.1230568-1230568

2023

Volltextzugriff (PDF)

A cell-penetrating peptide blocks Toll-like receptor-mediated downstream signaling and ameliorates autoimmune and inflammatory diseases in mice

Experimental and Molecular Medicine, 2019, 51(0), , pp.1-19

2019

Volltextzugriff (PDF)

1 – 25 von 1.002

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(846)
Mit Volltextzugriff
(867)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(29)
Journal Of Medicinal Chemistry
(29)
Cancer Research
(26)
The New England Journal Of Medicine
(18)
Clinical Cancer Research
(17)
Gastrointestinal Endoscopy
(15)
Bioorganic & Medicinal Chemistry Letters
(13)
Gastroenterology
(13)
Cell
(12)
Cell Reports
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A review of osteocyte function and the emerging importance of sclerostin

Gremlin 1 Identifies a Skeletal Stem Cell with Bone, Cartilage, and Reticular Stromal Potential

Bone Quality and Fracture-Healing in Type-1 and Type-2 Diabetes Mellitus

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia

Efficient differentiation of human iPSC-derived mesenchymal stem cells to chondroprogenitor cells

The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants

Preclinical discovery of ixabepilone, a highly active antineoplastic agent

Targeting Multiple Kinase Pathways in Leukemic Progenitors and Stem Cells Is Essential for Improved Treatment of Ph⁺ Leukemia in Mice

Transcriptomic identification of genes expressed in invasive S. aureus diabetic foot ulcer infection

Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)–based mutagenesis screen: high efficacy of drug combinations

Action of the src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells

In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants

Additive manufacturing of hydrogel-based materials for next-generation implantable medical devices

Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival

Metabolism and disposition of dasatinib after oral administration to humans

Stem cell‐directed therapies for osteoarthritis: The promise and the practice

Comparative Analysis of Two Clinically Active BCR-ABL Kinase Inhibitors Reveals the Role of Conformation-Specific Binding in Resistance

Unique Spatial Transcriptomic Profiling of the Murine Femoral Fracture Callus: A Preliminary Report

Concurrent targeting of glycolysis in bacteria and host cell inflammation in septic arthritis

Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL

Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on src kinase for survival

Re-appraising the potential of naringin for natural, novel orthopedic biotherapies

Preclinical efficacy spectrum and pharmacokinetics of ixabepilone

Parathyroid hormone therapy improves MRSA-infected fracture healing in a murine diabetic model

A cell-penetrating peptide blocks Toll-like receptor-mediated downstream signaling and ameliorates autoimmune and inflammatory diseases in mice

Suchergebnisse filtern